The Molecular Basis Of Experimental Oxygen-induced Retinopathy
Funder
National Health and Medical Research Council
Funding Amount
$82,924.00
Summary
Retinopathy of prematurity is a potentially blinding eye disease that affects some very low birth-weight premature infants given oxygen therapy. Determining which infants are likely to be severely affected is currently difficult. Using an experimental animal model, the aim of this project is to investigate genetic factors that may be used to identify those infants who are most at risk of developing disabling retinopathy.